- Home
- NGS vs BCYC Comparison
NGS vs BCYC Comparison
Compare NGS & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGS | BCYC |
|---|---|---|
| Founded | 1998 | 2009 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 475.1M | 360.7M |
| IPO Year | 2006 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NGS | BCYC |
|---|---|---|
| Price | $36.17 | $5.04 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $39.00 | $17.56 |
| AVG Volume (30 Days) | 82.4K | ★ 328.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | ★ 260.53 | 42.91 |
| EPS | ★ 1.25 | N/A |
| Revenue | ★ $156,742,000.00 | N/A |
| Revenue This Year | $9.83 | N/A |
| Revenue Next Year | $14.49 | N/A |
| P/E Ratio | $30.51 | ★ N/A |
| Revenue Growth | ★ 29.36 | N/A |
| 52 Week Low | $16.73 | $5.03 |
| 52 Week High | $39.67 | $10.32 |
Technical Indicators
Market Signals| Indicator | NGS | BCYC |
|---|---|---|
| Relative Strength Index (RSI) | 44.19 | 35.35 |
| Support Level | $32.52 | $5.03 |
| Resistance Level | $39.67 | $5.90 |
| Average True Range (ATR) | 1.41 | 0.27 |
| MACD | -0.25 | -0.00 |
| Stochastic Oscillator | 12.36 | 5.59 |
Price Performance
Historical ComparisonAbout NGS Natural Gas Services Group Inc.
Natural Gas Services Group Inc provides natural gas compression equipment and services to the energy industry. The company manufactures, fabricates, rents, sells, and maintains natural gas compressors and flare systems for oil and natural gas production and plant facilities. Its operating units include Rental, Sales, and Aftermarket services. The company generates the majority of its revenue by renting out low- to medium-horsepower compression equipment to natural gas production companies in unconventional oil and gas regions of the United States.
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.